Kathryn M. Kitrinos

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

Patrick Marcellin, Edward Gane, Nezam H. Afdhal et al. · The Lancet · 2012 · 1.7K citations

Hepatology, Viral Hepatitis, Liver Physiology +9

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

Henry Lik‐Yuen Chan, Scott Fung, Wai Kay Seto et al. · ˜The œLancet. Gastroenterology & hepatology · 2016 · 447 citations

Hepatology, Viral Hepatitis, Hepatitis B +9

Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease

Yun‐Fan Liaw, I‐Shyan Sheen, Chuan–Mo Lee et al. · Hepatology · 2010 · 319 citations

Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection

Naoky Tsai, Joerg Petersen, Robert Flisiak et al. · Digestive Diseases and Sciences · 2014 · 297 citations · Full text

No Detectable Resistance to Tenofovir Disoproxil Fumarate After 6 Years of Therapy in Patients With Chronic Hepatitis B

Kathryn M. Kitrinos, Amoreena C. Corsa, Yang Liu et al. · Hepatology · 2013 · 225 citations · Full text